MONTELUKAST for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 21 adverse event reports in the FDA FAERS database where MONTELUKAST was used for Psoriasis.
Most Reported Side Effects for MONTELUKAST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 8,372 | 31.0% | 208 | 3,766 |
| Dyspnoea | 6,354 | 23.6% | 88 | 3,164 |
| Wheezing | 5,159 | 19.1% | 52 | 2,588 |
| Drug ineffective | 3,539 | 13.1% | 142 | 1,358 |
| Cough | 3,475 | 12.9% | 25 | 1,633 |
| Therapeutic product effect incomplete | 3,352 | 12.4% | 55 | 1,765 |
| Anxiety | 2,994 | 11.1% | 72 | 666 |
| Loss of personal independence in daily activities | 2,736 | 10.1% | 42 | 1,539 |
| Sleep disorder due to a general medical condition | 2,101 | 7.8% | 46 | 1,156 |
| Obstructive airways disorder | 2,073 | 7.7% | 45 | 1,209 |
| Pneumonia | 2,071 | 7.7% | 78 | 890 |
| Headache | 2,047 | 7.6% | 132 | 642 |
| Depression | 2,041 | 7.6% | 37 | 419 |
| Fatigue | 1,959 | 7.3% | 131 | 604 |
| Drug hypersensitivity | 1,792 | 6.6% | 122 | 313 |
Other Indications for MONTELUKAST
Product used for unknown indication (11,960)
Asthma (7,298)
Hypersensitivity (852)
Multiple allergies (518)
Chronic spontaneous urticaria (416)
Rhinitis allergic (344)
Ill-defined disorder (222)
Seasonal allergy (220)
Cough (202)
Urticaria (157)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)